Letters by company

Holmen AB ADR

2 letters discussing HLMNY. Everything written about it on this site is on its ticker page.

Protean Funds Paper Profits, Pulp Fiction Protean Funds shorted Holmen, arguing that Nordic pulp and paper economics face eucalyptus competition, rising wood costs, climate-related forestry risks and an unsustainable ESG premium. Protean Small Cap added Arctic Falls and Afry, tendered Addvise and sold Nilfisk after takeover bids, while the firm considers a low-fee global Aktiesparfond. December 2025 HLMNY $4.9BARFA $62M
Protean Funds Bats With Rabies Protean launched Aktiesparfond Global as a low-cost active alternative built around disciplined capital allocation and manager Olle Qvarnström. Small Cap added Surgical Science on depressed valuation and backed Bavarian Nordic's vaccine franchise. Select covered its Holmen short, bought other pulp and forestry names, and added to its Essity short. August 2026 BVNKF $2.6BSUSRF $274M